Search research articles
Contact Us
Filters
Showing results (331-340 of 361) with videos related to
Page
of 37
Sort By:
Journal of the National Cancer Institute
|
February 25, 2020
Durability of Cross-Protection by Different Schedules of the Bivalent HPV Vaccine: The CVT Trial
Sabrina H Tsang, Joshua N Sampson, John Schussler, et al.
Journal of the National Cancer Institute
|
September 28, 2017
Durability of Protection Afforded by Fewer Doses of the HPV16/18 Vaccine: The CVT Trial
Mahboobeh Safaeian, Joshua N Sampson, Yuanji Pan, et al.
Vaccine
|
July 22, 2008
Rationale and design of a community-based double-blind randomized clinical trial of an HPV 16 and 18 vaccine in Guanacaste, Costa Rica
Rolando Herrero, Allan Hildesheim, Ana C Rodríguez, et al.
American Journal of Epidemiology
|
August 21, 2014
Effect of different human papillomavirus serological and DNA criteria on vaccine efficacy estimates
Krystle A Lang Kuhs, Carolina Porras, John T Schiller, et al.
Journal of the National Cancer Institute
|
May 31, 2022
Performance of Cervical Screening a Decade Following HPV Vaccination: The Costa Rica Vaccine Trial
Shang-Ying Hu, Aimée R Kreimer, Carolina Porras, et al.
The Journal of Allergy and Clinical Immunology
|
November 8, 2017
Ruxolitinib partially reverses functional natural killer cell deficiency in patients with signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations
Alexander Vargas-Hernández, Emily M Mace, Ofer Zimmerman, et al.
The Lancet. Oncology
|
December 3, 2020
Efficacy of the bivalent HPV vaccine against HPV 16/18-associated precancer: long-term follow-up results from the Costa Rica Vaccine Trial
Carolina Porras, Sabrina H Tsang, Rolando Herrero, et al.
Journal of the National Cancer Institute
|
February 25, 2020
Evaluation of Durability of a Single Dose of the Bivalent HPV Vaccine: The CVT Trial
Aimée R Kreimer, Joshua N Sampson, Carolina Porras, et al.
Vaccine
|
March 23, 2015
Rationale and design of a long term follow-up study of women who did and did not receive HPV 16/18 vaccination in Guanacaste, Costa Rica
Paula Gonzalez, Allan Hildesheim, Rolando Herrero, et al.
Journal of the American Heart Association
|
October 7, 2020
Antecedent Administration of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Antagonists and Survival After Hospitalization for COVID-19 Syndrome
Alberto Palazzuoli, Massimo Mancone, Gaetano M De Ferrari, et al.
Page
of 37
Search research articles
Search
Showing results (331-340 of 361) with videos related to
Sort By:
Page
of 37
Journal of the National Cancer Institute
|
February 25, 2020
Durability of Cross-Protection by Different Schedules of the Bivalent HPV Vaccine: The CVT Trial
Sabrina H Tsang, Joshua N Sampson, John Schussler, et al.
Journal of the National Cancer Institute
|
September 28, 2017
Durability of Protection Afforded by Fewer Doses of the HPV16/18 Vaccine: The CVT Trial
Mahboobeh Safaeian, Joshua N Sampson, Yuanji Pan, et al.
Vaccine
|
July 22, 2008
Rationale and design of a community-based double-blind randomized clinical trial of an HPV 16 and 18 vaccine in Guanacaste, Costa Rica
Rolando Herrero, Allan Hildesheim, Ana C Rodríguez, et al.
American Journal of Epidemiology
|
August 21, 2014
Effect of different human papillomavirus serological and DNA criteria on vaccine efficacy estimates
Krystle A Lang Kuhs, Carolina Porras, John T Schiller, et al.
Journal of the National Cancer Institute
|
May 31, 2022
Performance of Cervical Screening a Decade Following HPV Vaccination: The Costa Rica Vaccine Trial
Shang-Ying Hu, Aimée R Kreimer, Carolina Porras, et al.
The Journal of Allergy and Clinical Immunology
|
November 8, 2017
Ruxolitinib partially reverses functional natural killer cell deficiency in patients with signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations
Alexander Vargas-Hernández, Emily M Mace, Ofer Zimmerman, et al.
The Lancet. Oncology
|
December 3, 2020
Efficacy of the bivalent HPV vaccine against HPV 16/18-associated precancer: long-term follow-up results from the Costa Rica Vaccine Trial
Carolina Porras, Sabrina H Tsang, Rolando Herrero, et al.
Journal of the National Cancer Institute
|
February 25, 2020
Evaluation of Durability of a Single Dose of the Bivalent HPV Vaccine: The CVT Trial
Aimée R Kreimer, Joshua N Sampson, Carolina Porras, et al.
Vaccine
|
March 23, 2015
Rationale and design of a long term follow-up study of women who did and did not receive HPV 16/18 vaccination in Guanacaste, Costa Rica
Paula Gonzalez, Allan Hildesheim, Rolando Herrero, et al.
Journal of the American Heart Association
|
October 7, 2020
Antecedent Administration of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Antagonists and Survival After Hospitalization for COVID-19 Syndrome
Alberto Palazzuoli, Massimo Mancone, Gaetano M De Ferrari, et al.
Page
of 37